The risk of COVID-19 in patients with psoriasis: A retrospective cohort study

Published: 25 July 2022| Version 1 | DOI: 10.17632/68fht87h68.1
Jashin Wu, Jeffrey Liu, Akshitha Thatiparthi, Amylee Martin, Alexander Egeberg


Supplement I. CONSORT diagram for the cohorts of patients with psoriasis. PsA, psoriatic arthritis Supplement II. Multivariable Logistic Regression Assessing Factors (ICD-10) Associated with COVID-19 Infection aMultivariable logistic regression models were constructed with COVID-19 as the dependent variable, psoriasis as the independent variable, and the following covariates: age (linear), sex (male vs. female), race (Caucasian vs. non-caucasian), congestive heart failure, chronic obstructive pulmonary disease, type-2 diabetes mellitus, and obesity. Adjusted odds ratios were computed for patients with psoriasis and general population controls. P-value less than 0.05 was considered significant. Bold values indicate significant results.



Epidemiology of Psoriasis, COVID-19